Reinhart Partners LLC. Sells 31,105 Shares of Encompass Health Corporation $EHC

Reinhart Partners LLC. trimmed its holdings in Encompass Health Corporation (NYSE:EHC) by 7.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 404,257 shares of the company’s stock after selling 31,105 shares during the period. Reinhart Partners LLC. owned 0.41% of Encompass Health worth $49,113,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Ancora Advisors LLC acquired a new position in shares of Encompass Health during the 2nd quarter worth $10,639,000. Canada Pension Plan Investment Board bought a new position in Encompass Health in the second quarter valued at about $7,723,000. Trillium Asset Management LLC grew its position in Encompass Health by 5.7% in the fourth quarter. Trillium Asset Management LLC now owns 217,734 shares of the company’s stock valued at $23,424,000 after acquiring an additional 11,793 shares during the last quarter. Oppenheimer Asset Management Inc. acquired a new position in Encompass Health during the second quarter worth about $2,620,000. Finally, VELA Investment Management LLC lifted its holdings in shares of Encompass Health by 53.6% in the second quarter. VELA Investment Management LLC now owns 48,991 shares of the company’s stock worth $4,952,000 after acquiring an additional 17,105 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on EHC shares. TD Cowen raised their price target on shares of Encompass Health from $125.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Barclays increased their price objective on shares of Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Weiss Ratings upgraded shares of Encompass Health from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, September 26th. Finally, UBS Group increased their price target on Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $148.50.

Encompass Health Stock Performance

NYSE:EHC opened at $123.33 on Friday. The company has a market capitalization of $12.17 billion, a PE ratio of 20.09, a P/E/G ratio of 2.48 and a beta of 0.74. The company has a 50 day simple moving average of $121.57 and a two-hundred day simple moving average of $110.57. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.19 and a current ratio of 1.19. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same period in the prior year, the firm posted $1.40 EPS. The company’s quarterly revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Research analysts anticipate that Encompass Health Corporation will post 6.08 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.21 dividend. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is 13.68%.

Insider Transactions at Encompass Health

In other Encompass Health news, CEO Mark J. Tarr sold 173,148 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the transaction, the chief executive officer directly owned 267,814 shares in the company, valued at approximately $33,602,622.58. This represents a 39.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John Darby sold 8,906 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the sale, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. This trade represents a 10.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 186,912 shares of company stock worth $23,434,845 over the last three months. 1.80% of the stock is owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation (NYSE:EHC) is a healthcare services company focused on inpatient rehabilitation. Through its network of rehabilitation hospitals, the company provides intensive medical and therapeutic care to patients recovering from conditions such as strokes, brain and spinal cord injuries, hip fractures, amputations, neurological disorders, and other disabling illnesses or injuries.

Its rehabilitation hospitals offer coordinated care from physicians, nurses, therapists, and other healthcare professionals.